Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr O'Rourke received his medical training at George Washington University School of Medicine and his residency training at David Grant USAF Medical Center in California. Following the completion of his rheumatology fellowship training at the University of Michigan Medical Center in 1992 he has served as a clinician educator faculty member in the Section on Rheumatology and Immunology at Wake Forest University School of Medicine. He has directed the rheumatology fellowship training program at Wake Forest since 1995, and served as Section Head from 2000-2007.
Dr O'Rourke's clinical interests are in geriatric rheumatology, myopathies, and rehabilitative therapies in rheumatic disease. He has interventional skill expertise in needle muscle biopsy and minor salivary gland biopsy, and has co-instructed the arthrocentesis workshops at the ACR Annual Meetings with Atul Deodhar. His current research interests are focused on curricular development in rheumatology, and developing teaching strategies for small-group, problem-based instruction.
Dr O'Rourke was the recipient of the Clinician Scholar Educator Award from the ACR, and has also held leadership roles within the organization. He has served as a member and then Chair of the Executive Committee of the Rehabilitation Section, is currently a member on the Committee on Education and the Continuing Assessment, Review, and Evaluation (CARE) Development Group, and has served as member on the Annual Meeting Planning Committee and the Subcommittee on Medical Education.
John S. Sundy is associate professor of medicine and Head of the Section of Adult Allergy, and Clinical Immunology in the Division of Pulmonary, Allergy and Critical Care Medicine at Duke University Medical Center. He received his medical training at Hahnemann University and residency and fellowship training at Duke University Medical Center. He is board certified in the fields of Rheumatology and Allergy/Immunology. Dr Sundy is a leader in clinical trials of novel therapies for gout. His additional research interests include translational studies in inflammatory diseases such as asthma and allergic rhinitis. He is director of the adult allergy training program at Duke, and is director of rheumatology research at the Duke Clinical Research Institute. Dr Sundy's clinical practice includes patients with allergic, rheumatologic and immunologic disorders.
Robert received his M.D.-Ph.D. in 2000 from Case Western Reserve University; he completed his residency in internal medicine at University of California, San Francisco in 2002, and clinical fellowship training in Rheumatology at Brigham and Women's Hospital in 2006. He did his post-doctoral research training with David Altshuler at the Broad Institute. Robert was recently awarded the Young Investigator Award (2008) in the Department of Medicine (Brigham and Women's Hospital), a Career Award for Medical Scientists through the Burroughs Wellcome Fund (2008); and an Excellence in Tutoring Award given by Harvard Medical School (2007 and 2008).
Dr Solomon received his medical training at Yale School of Medicine and his residency training at Boston City Hospital and Brigham and Women's Hospital, both in Boston. He was a fellow in rheumatology at Brigham and Women's Hospital and received a masters degree in Public Health at Harvard. Until this year, he had served as the director of health services research in the Division of Pharmacoepidemiology at Brigham and Women's Hospital. He was appointed Chief of the Section of Clinical Sciences in Rheumatology during 2007.
Dr Solomon's work has focused on three areas. First, he has been a leader in the area of drug safety and pharmacoepidemiology of rheumatic disease treatments. He originally focused on the safety of non-steroidal anti-inflammatory drugs with respect to cardiovascular toxicity. Subsequent work has focused on comparing non-selective and selective NSAIDs in their cardiovascular risk profile. Dr Solomon has led other efforts examining the safety of TNFα antagonists with respect to cancer, lymphoma, and infectious complications. Second, he has focused on the epidemiology of cardiovascular disease in rheumatoid arthritis. His work with Dr Elizabeth Karlson on the Nurses' Health Study stands as one of the largest epidemiologic investigations of cardiovascular disease in rheumatoid arthritis. Finally, he has investigated patterns of care for osteoporosis which led to the development and testing of several innovative improvement strategies, for osteoporosis management.
Dr Solomon has also played leadership roles in the American College of Rheumatology. He has served as co-chair of the Subcommittee on Classification and Response Criteria with Jasvinder Singh. Currently, he serves as the Chair of the Quality of Care Committee overseeing work on Guidelines, Quality Measures, Criteria Sets, and Drug Safety. In the past, he has served on several different committees of the Arthritis Foundation.